Pulmonary artery carries blood from the right ventricle of the heart to the lungs for purification. Pulmonary artery catheterization is a procedure, wherein a catheter is inserted into the pulmonary artery. The flow-directed balloon-tipped pulmonary artery catheter was first discussed in 1970 and was initially developed for the management of acute myocardial infarction. It was widely used in the management of various critical illnesses and surgical procedures. Pulmonary artery catheterization is a diagnostic procedure, in which a small catheter is inserted either through neck, arm, chest, or thigh vein and moved toward the right side of the heart in order to measure the pressure of the heart.
Request Brochure for Report –
Global Pulmonary Artery Catheter Witness Most Promising Rise in Demand
The global pulmonary artery catheter market is driven by the use of pulmonary artery catheter in the preoperative, perioperative, and postoperative treatment. Above this, with rising health issues due to sedentary lifestyle and unhealthy dietary habits has increased the number of cases with cardiac complications have increased. Moreover, sedentary lifestyle and dietary habits, and increase in smoking and drinking habits are responsible for increased cardiac complications. Furthermore, rise in the geriatric population is a major factor driving the number of pulmonary artery catheterization procedures. Pulmonary artery catheterization is useful in taking standard care of all critically ill patients. However, it offers no benefits for patients with septic shocks, acute respiratory distress syndrome, and also in the routine treatment of patients undergoing high-risk of surgery.
The global pulmonary artery catheter market can be segmented based on type, application, end-user, and region. In terms of type, the market can be classified into four-lumen catheter, five-lumen catheter, six-lumen catheter, and others. Based on application, the global pulmonary artery catheter market can be bifurcated into ICU use and non-ICU use. In terms of end-user, the market can be divided into hospitals, cardiac clinics, and ambulatory surgical centers.
Request for Analysis of COVID19 Impact on Pulmonary Artery Catheter–
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touch points. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
Key Players of Pulmonary Artery Catheter Report:
Leading players in the global pulmonary artery catheter market are Edward Lifesciences Corporation, Argon Medical Devices, Inc., ICU Medical, Inc., Biosensors International Group, VICTUS, and B. Braun Melsungen AG.
Buy Pulmonary Artery Catheter Report –
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453